Op-Ed: Self-GRAS Isn’t a Loophole. It’s A Lifeline for Food Innovation

Simo Ellilä, co-founder and CEO of Enifer, argues why the self-affirmed GRAS pathway – set to be eliminated by the US FDA this year – is worth preserving.

As the FDA reviews its framework for self-affirmed GRAS determinations, many in the food industry are watching closely. The discussion, sparked by renewed scrutiny of additives and colourants, touches on a larger question: how can the US maintain the world’s highest food-safety standards while supporting the science that drives new nutrition and sustainability solutions?

The self-GRAS pathway – which allows companies to demonstrate ingredient safety through independent expert review – has long balanced these goals. It allows scientists and startups to apply the same rigorous standards as large corporations while providing a feasible route to advance new proteins, fibres, and functional ingredients. 

That balance is worth protecting. If the FDA narrows or weakens the self-affirmed GRAS process, it risks slowing precisely the kind of science-based innovation that can improve both public health and environmental outcomes. Self-GRAS is not a loophole; it is an essential part of how credible research moves from the lab to the marketplace.

What self-GRAS is (and isn’t)

Far from being a shortcut, self-affirmed GRAS is often where the most rigorous safety work begins. As such, “self-affirmed” doesn’t mean unregulated; it means companies take on the responsibility of compiling the same depth of scientific evidence the FDA itself would require. The process ensures that food-safety data are generated early and thoroughly, and provides the agency with a well-developed scientific record to reference if it later chooses to review the ingredient formally.

Each determination is based on comprehensive scientific evidence and published peer-reviewed studies covering the ingredient’s composition, dietary exposure, intended use, toxicology and history of safe consumption. These data are critically evaluated by an independent panel of qualified experts – often former regulators or academic specialists. These panels frequently request additional data or revisions before an ingredient can be affirmed as safe. In practice, the process demands both transparency and scientific rigour; accountability comes through evidence, not paperwork.

Formal regulatory reviews can take years, not because of weak science but due to the resource constraints and procedural backlog facing public agencies. That delay can make it difficult for smaller innovators with strong data to bring solutions to market in time to meet pressing food, climate, or health challenges.

Self-GRAS helps bridge that gap. It enables safe, science-backed innovations – such as microbial proteins and alternative fats – to reach consumers faster while maintaining full scientific scrutiny. By comparison, Europe’s precautionary approach often results in multi-year approval timelines, delaying even well-substantiated ingredients. The relative responsiveness of the US framework has therefore become a practical advantage, attracting many European innovators who see self-GRAS as a way to bring credible science to market more efficiently.

Why preserving self-GRAS matters for US competitiveness

Indeed, Europe’s precautionary approach has already prompted a generation of sustainable-protein innovators to look westward. If the United States were to limit or dismantle the self-affirmed GRAS pathway, it would risk adopting the same structural delays that have slowed product development elsewhere.

Removing self-GRAS would also concentrate opportunity among large corporations able to finance lengthy review cycles, leaving early-stage innovators at a disadvantage. For many smaller research-driven companies, the ability to generate and validate safety data through independent expert review is the only viable route to bring science-based solutions to market.

That accessibility has made the US an attractive environment for credible innovation. European food-tech startups such as Solar Foods, All G, and Enifer have pursued US entry precisely because the framework rewards strong evidence and timely review. Without it, those same breakthroughs would likely move to regions where regulatory systems are better resourced or more adaptable.

Self-GRAS serves as a democratizing mechanism, giving qualified scientists and startups a path to compete on the strength of their data, not the size of their compliance budgets. To achieve self-affirmed status, companies must assemble comprehensive safety data and submit it to an independent panel of experts in toxicology, food science, and regulatory affairs – experts whose credentials mirror those of the FDA’s own specialists and who can require further analyses before reaching a conclusion.

Importantly, companies remain fully accountable for their determinations and are subject to FDA enforcement if new evidence later contradicts their findings. Weakening this framework would not enhance consumer protection; it would only constrain the pace at which safe, sustainable innovations can reach the market.

The way forward

The FDA’s role in safeguarding public health is indispensable. The agency continually evaluates the safety of food compounds – from enzymes and flavourings to packaging materials and botanicals – and re-examines its conclusions as new scientific evidence emerges. That cycle of review and re-review is what gives US consumers confidence in their food supply.

Still, reform does not have to mean restriction. The self-affirmed GRAS framework can be strengthened in ways that build public trust without compromising its efficiency. Practical steps include establishing an accredited expert registry to ensure panel quality, implementing post-market monitoring to collect long-term data, and publishing summary disclosures of key safety findings. These measures would refine the process, not replace it.

At a moment when the world urgently needs new, sustainable food technologies, slowing the science that makes them possible would be shortsighted. Many of today’s food-tech startups are tackling challenges far beyond novelty: reducing agriculture’s environmental footprint, improving nutritional quality, and addressing public-health burdens such as obesity and metabolic disease. Food innovation is part of the solution, and the regulatory framework must evolve to keep pace.

The answer to imperfect regulation is not to halt progress but to let science lead while ensuring oversight grows alongside it.

Protect consumers and foster progress

The self-affirmed GRAS process embodies a core strength of the US regulatory tradition: trust in science, accountability in practice, and the freedom to innovate responsibly.

For decades, it has allowed researchers and entrepreneurs to compete on evidence rather than influence, creating a more dynamic and responsive food system. Rolling it back would not make food safer; it would make progress slower and innovation rarer.

America’s strength has always come from empowering experts to act, not forcing them to wait. If the FDA’s goal is to both protect consumers and foster progress, the path forward is to modernise self-GRAS, not dismantle it. When bureaucracy is mistaken for safety, we do not advance public health, we simply stop moving forward.